Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuji Murakami

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Brain, Behavior, & Immunity - Health|February 3, 2026
Quinolinic acid as trigger/biomarker of dysosmia/dysgeusia in patients with acute coronavirus disease 2019: A retrospective case-control studyJun Tsukiji, Shiro Koizume, Tomoko Takahashi, et al.
The Annals of Thoracic Surgery|January 27, 2015
Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinomaShinsuke Sasada, Haruhiko Nakayama, Yoshihiro Miyata, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation SequencingShuji Murakami, Tomoyuki Yokose, Daiji Nemoto, et al.
Arthritis and Rheumatism|February 1, 2007
Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytesYohei Kirino, Mitsuhiro Takeno, Shuji Murakami, et al.
Thoracic Cancer|June 25, 2020
Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next-generation sequencing techniqueSaki Manabe, Rika Kasajima, Shuji Murakami, et al.
Therapeutic Advances in Medical Oncology|January 29, 2024
Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase, et al.
Future Oncology (London, England)|August 14, 2023
Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study)Yusuke Okuma, Shogo Nomura, Kiichiro Ninomiya, et al.
Thoracic Cancer|March 27, 2019
Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancerNobumasa Tamura, Hidehito Horinouchi, Katsutoshi Sekine, et al.
Thoracic Cancer|October 27, 2020
Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non-small cell lung cancer treated with anti-PD-1 antibodyShuji Murakami, Ryota Shibaki, Yuji Matsumoto, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2015
Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinomaShuji Murakami, Hiroyuki Ito, Norifumi Tsubokawa, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Brain, Behavior, & Immunity - Health|February 3, 2026
Quinolinic acid as trigger/biomarker of dysosmia/dysgeusia in patients with acute coronavirus disease 2019: A retrospective case-control studyJun Tsukiji, Shiro Koizume, Tomoko Takahashi, et al.
The Annals of Thoracic Surgery|January 27, 2015
Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinomaShinsuke Sasada, Haruhiko Nakayama, Yoshihiro Miyata, et al.
Diagnostics (Basel, Switzerland)|March 6, 2021
Suitability of Bronchoscopic Biopsy Tissue Samples for Next-Generation SequencingShuji Murakami, Tomoyuki Yokose, Daiji Nemoto, et al.
Arthritis and Rheumatism|February 1, 2007
Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytesYohei Kirino, Mitsuhiro Takeno, Shuji Murakami, et al.
Thoracic Cancer|June 25, 2020
Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next-generation sequencing techniqueSaki Manabe, Rika Kasajima, Shuji Murakami, et al.
Therapeutic Advances in Medical Oncology|January 29, 2024
Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase, et al.
Future Oncology (London, England)|August 14, 2023
Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study)Yusuke Okuma, Shogo Nomura, Kiichiro Ninomiya, et al.
Thoracic Cancer|March 27, 2019
Efficacy of subsequent docetaxel +/- ramucirumab and S-1 after nivolumab for patients with advanced non-small cell lung cancerNobumasa Tamura, Hidehito Horinouchi, Katsutoshi Sekine, et al.
Thoracic Cancer|October 27, 2020
Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non-small cell lung cancer treated with anti-PD-1 antibodyShuji Murakami, Ryota Shibaki, Yuji Matsumoto, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2015
Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinomaShuji Murakami, Hiroyuki Ito, Norifumi Tsubokawa, et al.
Pageof 12